liriodenine has been researched along with bromodeoxyuridine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, TT; Chen, CH; Chern, CL; Hsieh, PY; Hsieh, TJ; Hu, HS; Liu, TZ; Lu, FJ; Syu, YH; Tsao, DA | 1 |
1 other study(ies) available for liriodenine and bromodeoxyuridine
Article | Year |
---|---|
Liriodenine inhibits the proliferation of human hepatoma cell lines by blocking cell cycle progression and nitric oxide-mediated activation of p53 expression.
Topics: Antimetabolites; Antineoplastic Agents, Phytogenic; Aporphines; Blotting, Western; Bromodeoxyuridine; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Chromatography, Thin Layer; DNA, Neoplasm; Dose-Response Relationship, Drug; Flow Cytometry; Gene Expression; Genes, p53; Humans; Magnetic Resonance Spectroscopy; Magnoliaceae; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Tumor Cells, Cultured | 2005 |